The association between antimicrobial resistance mutations and treatment outcomes for Mycoplasma genitalium infections from 2018 to 2022: a cross-sectional study from Auckland, New Zealand

18  Shipitsyna E, Khusnutdinova T, Budilovskaya O, Shedko E, Goloveshkina E, Khayrullina G, Krysanova A, Shalepo K, Savicheva A, Unemo M. Performance of the first commercial dual resistance assay, AmpliSens Mycoplasma genitalium-ML/FQ-Resist-FL, for detection of potential macrolide and quinolone resistance-associated mutations and prevalence of M. genitalium resistance mutations in St. Petersburg, Russia. Sex Transm Infect 2023; 99(3): 191-194.
| Crossref | Google Scholar | PubMed |

留言 (0)

沒有登入
gif